Methylcellulose

Basic Information

Item Value
DrugBank ID DB11228
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 26

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 osteoarthritis KG + DL
2 enterocolitis (disease) KG + DL
3 alopecia KG + DL
4 pseudoachondroplasia KG + DL
5 hypotrichosis simplex of the scalp KG + DL
6 congenital hypotrichosis milia KG + DL
7 diffuse alopecia areata KG + DL
8 insomnia (disease) KG + DL
9 exercise-induced malignant hyperthermia KG + DL
10 osteoarthritis susceptibility KG + DL
11 phaeochromocytoma KG + DL
12 sympathetic paraganglioma KG + DL
13 acromesomelic dysplasia, Hunter-Thompson type KG + DL
14 nephrogenic syndrome of inappropriate antidiuresis KG + DL
15 brachyolmia KG + DL
16 myosclerosis KG + DL
17 brachyolmia-amelogenesis imperfecta syndrome KG + DL
18 malignant hyperthermia of anesthesia KG + DL
19 autonomic nervous system neoplasm KG + DL
20 non-secreting paraganglioma KG + DL
21 parasympathetic paraganglioma KG + DL
22 sporadic pheochromocytoma/secreting paraganglioma KG + DL
23 adrenal gland pheochromocytoma KG + DL
24 gastroenteritis KG + DL
25 arthropathy KG + DL
26 small intestine cancer KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.